Back to results
US 10,377,750 B2Granted
5-methyl-1,3,4-oxadiazol-2-yl compounds
AssigneeEli Lilly and Company
InventorsNicolas Jacques Francois Dreyfus, Peter James Lindsay-Scott, Richard Edmund Rathmell
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.
Claims13
A compound of the formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.